In this activity, a multidisciplinary team of specialists plus a patient advocate share their perspectives on recognizing the signs and symptoms of Duchenne muscular dystrophy, key considerations for the diagnosis and pre-symptomatic screening of the condition, and emerging novel therapies for its medical management.
This activity has been designed to meet the educational needs of cardiologists, clinical geneticists, endocrinologists, gastroenterologists, neurologists, nurse specialists, orthopaedic surgeons, paediatricians, paediatric neurologists, physiotherapists, primary care physicians and pulmonologists involved in the management of Duchenne muscular dystrophy.
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Prof. Nancy Kuntz discloses: Advisory board/panel fees from Argenx, Astellas, Biogen, BioMarin, Genentech, Novartis, Parexel, Regeneron and Sarepta Therapeutics. Grants/research support from Argenx, Astellas, Biogen, BioMarin, Genentech, Novartis and Sarepta Therapeutics.
Dr Nadia Merchant discloses: Advisory board/panel fees from Biomarin and Pfizer. Grants/research support from Biomarin.
Dr Laura Kauffman has no interests/relationships or affiliations to disclose in relation to this activity.
Mr Filippo Buccella discloses: Advisory board/panel fees from PTC Therapeutics.
Deborah Cragun, PhD, MS, CGC, has no financial interests/relationships or affiliations in relation to this activity
Touch Medical Directors
Sola Neunie has no financial interests/relationships or affiliations in relation to this activity.
USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.
Requirements for Successful Completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.
If you have questions regarding credit please contact firstname.lastname@example.org.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).
Advanced Practice Providers
Physician Assistants may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.
Date of original release: 14 March 2023. Date credits expire: 14 March 2025.
If you have any questions regarding credit please contact email@example.com.